ICH Q12: innovadora y controvertida (parte 2)

dc.contributor.authorMonsonís Centelles, Laura
dc.contributor.authorGarcía Montoya, Encarna
dc.date.accessioned2022-02-24T12:50:57Z
dc.date.available2022-02-24T12:50:57Z
dc.date.issued2021-11-01
dc.date.updated2022-02-24T12:50:58Z
dc.description.abstractThis work has been published in two parts. In the first, the conceptual framework of the ICH and more specifically of the ICH Q12 was reviewed. In this second, and last, the regulatory and enabling tools of the ICH Q12 are reviewed, which is complemented by a practical part or 'survey' carried out with some professionals in the pharmaceutical industry, although the sample is very small and cannot be generalized, It is important to realize that more information and training on it is necessary at this time for its effective application.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec717780
dc.identifier.issn2340-2105
dc.identifier.urihttps://hdl.handle.net/2445/183451
dc.language.isospa
dc.publisherInfoedita
dc.relation.isformatofReproducció del document publicat a: https://https://www.pharmatech.es/kiosco/revista60#.Ye507OrM
dc.relation.ispartofPharmatech, 2021, num. 60, p. 80-91
dc.rights(c) Infoedita, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationTecnologia farmacèutica
dc.subject.classificationComprimits (Medicina)
dc.subject.classificationDesenvolupament de medicaments
dc.subject.otherPharmaceutical technology
dc.subject.otherTablets (Medicine)
dc.subject.otherDrug development
dc.titleICH Q12: innovadora y controvertida (parte 2)
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
717780.pdf
Mida:
827.64 KB
Format:
Adobe Portable Document Format